Liposome-encapsulated dexamethasone attenuates ventilator-induced lung inflammation. 2011

M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
Laboratory of Neuroimmunology and Developmental Origins of Disease, Utrecht, the Netherlands.

OBJECTIVE Systemic glucocorticoid therapy may effectively attenuate lung inflammation but also induce severe side-effects. Delivery of glucocorticoids by liposomes could therefore be beneficial. We investigated if liposome-encapsulated dexamethasone inhibited ventilator-induced lung inflammation. Furthermore, we evaluated whether targeting of cellular Fcγ-receptors (FcγRs) by conjugating immunoglobulin G (IgG) to liposomes, would improve the efficacy of dexamethasone-liposomes in attenuating granulocyte infiltration, one of the hallmarks of lung inflammation. METHODS Mice were anaesthetized, tracheotomized and mechanically ventilated for 5 h with either 'low' tidal volumes ∼7.5 mL·kg(-1) (LV(T) ) or 'high' tidal volumes ∼15 mL·kg(-1) (HV(T) ). At initiation of ventilation, we intravenously administered dexamethasone encapsulated in liposomes (Dex-liposomes), dexamethasone encapsulated in IgG-modified liposomes (IgG-Dex-liposomes) or free dexamethasone. Non-ventilated mice served as controls. RESULTS Dex-liposomes attenuated granulocyte infiltration and IL-6 mRNA expression after LV(T) -ventilation, but not after HV(T) -ventilation. Dex-liposomes also down-regulated mRNA expression of IL-1β and KC, but not of CCL2 (MCP-1) in lungs of LV(T) and HV(T) -ventilated mice. Importantly, IgG-Dex-liposomes inhibited granulocyte influx caused by either LV(T) or HV(T) -ventilation. IgG-Dex-liposomes diminished IL-1β and KC mRNA expression in both ventilation groups, and IL-6 and CCL2 mRNA expression in the LV(T) -ventilated group. Free dexamethasone prevented granulocyte influx and inflammatory mediator expression induced by LV(T) or HV(T) -ventilation. CONCLUSIONS FcγR-targeted IgG-Dex-liposomes are pharmacologically more effective than Dex-liposomes particularly in inhibiting pulmonary granulocyte infiltration. IgG-Dex-liposomes inhibited most parameters of ventilator-induced lung inflammation as effectively as free dexamethasone, with the advantage that liposome-encapsulated dexamethasone will be released locally in the lung thereby preventing systemic side-effects.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
January 2016, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
March 2008, The Journal of surgical research,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
July 2012, Critical care (London, England),
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
December 2015, European journal of pharmacology,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
January 2010, Critical care (London, England),
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
December 2010, Thorax,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
October 2021, Journal of theoretical biology,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
November 2020, bioRxiv : the preprint server for biology,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
June 2000, Critical care medicine,
M A Hegeman, and P M Cobelens, and Jaam Kamps, and M P Hennus, and N J G Jansen, and M J Schultz, and A J van Vught, and G Molema, and C J Heijnen
January 2015, International journal of clinical and experimental medicine,
Copied contents to your clipboard!